Contego Medical Announces European Commercialization of the Paladin® Carotid Post-­Dilation Balloon with Integrated Embolic Protection™ Technology

Presenting at the Leipzig Interventional Course (LINC) from
January 26th-­29th in Leipzig, Germany.

RALEIGH,  NC.  (January  14,  2016)  – Contego  Medical  today  announced  the  European  commercialization of the Paladin® Carotid Post-­Dilation Balloon, the first and only angioplasty  balloon  with  Integrated  Embolic  Protection™  (IEP)  Technology  for  patients  undergoing carotid stenting procedures. The innovative IEP platform, which combines embolic  protection  and  treatment  into  one  device,  is  designed  to  simplify  the  procedure  and improve patient outcomes.

“The Paladin System represents a significant development in embolic protection. In a single step  I  can  post-­dilate  the  carotid  stent  and  capture  smaller  embolic  debris  using  the  40-­micron filter,” commented Dr. Alberto Cremonesi, Director Interventional Cardio-­Angiology, Villa Maria Cecilia Hospital, Cotignola, Italy. “I look forward to more broadly using the intuitive system in my practice.”

The Paladin System improves outcomes by reducing the risk of embolization during post-­dilation, when the patient has the highest risk of embolic events. The single-­step system integrates a post-­dilation balloon proximally and an embolic protection filter at the distal catheter  tip.  Prior  to  post-­dilation,  the  physician  deploys  the  adjustable  40-­micron  filter  providing protection against both macro-­ and micro-­embolic debris. The intuitive and versatile system enhances a physician’s ability to treat carotid stenosis.

“The European launch of the Paladin System marks a major milestone for Contego,” stated Dr. Ravish Sachar, Founder and CEO of Contego Medical. “After receiving approval in 2015 the European post market registry results have been very positive. We are excited to bring this treatment option to European physicians and patients.”

The  Paladin  System  will  be  presented  and  featured  in  live  cases  at  LINC  on  Tuesday,  January 26th during the Technical Forum session “Deep Dive Session: Carotid Revascularization.”

About Contego Medical
Contego Medical, LLC, a privately held medical device company, has developed a portfolio of  novel  products  to  address  unmet  needs  in  the  cardiovascular  and  peripheral  vascular  space. Contego’s innovative solutions integrate filter-­based embolic protection and treatment  into  a  single  device.  Their  product  portfolio  is  poised  to  transform cardiovascular and endovascular intervention by making existing procedures safer without increasing complexity or compromising performance. Physicians Ravish Sachar MD and Jay Yadav MD, thought leaders and proven entrepreneurs, founded Contego in 2005.

Learn more at

Paul Sanders
Chief Operating Officer